Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab.
about
New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein OcclusionShort-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab.Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion.
P2860
Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@en
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@nl
type
label
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@en
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@nl
prefLabel
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@en
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@nl
P2093
P2860
P356
P1476
Twelve-month outcomes in patie ...... ency intravitreal ranibizumab.
@en
P2093
Ayumi Usui-Ouchi
Nobuyuki Ebihara
Yoshihito Sakanishi
P2860
P304
P356
10.2147/OPTH.S107594
P407
P577
2016-06-21T00:00:00Z